GPR12 Activators are a class of compounds that interact with or influence the signaling pathways of the G protein-coupled receptor GPR12. These activators can enhance the receptor's activity by engaging with the complex network of intracellular signaling cascades that GPR12 is part of. Sphingosine-1-phosphate (S1P), for instance, is a lipid signaling molecule that binds to GPR12, leading to the activation of downstream signaling pathways involving calcium mobilization and inhibition of adenylyl cyclase. This interaction enhances GPR12's ability to respond to external stimuli and propagate cellular responses. Similarly, lysophosphatidic acid (LPA) stimulates GPR12 by activating G proteins, which in turn initiate a series of intracellular events such as the activation of phospholipase C. This leads to the generation of diacylglycerol and inositol trisphosphate, second messengers that further modulate cellular functions associated with GPR12.
Other compounds like anandamide and 2-Arachidonoylglycerol (2-AG) are part of the endocannabinoid system and act on G protein-coupled receptors like GPR12 to trigger signaling mechanisms that enhance the receptor's activity. Anandamide's binding to GPR12 can facilitate the activation of the PI3K/AKT pathway, which is crucial for several cellular processes. On the other hand, 2-AG can inhibit adenylyl cyclase and activate MAPK, which are key pathways in GPR12 signaling. Adenosine and uridine diphosphate (UDP) are purines that interact with their respective G protein-coupled receptors, and through signaling cross-talk, they can enhance the function of GPR12. Additionally, compounds like FTY720 and VPC 23019 modulate sphingosine 1-phosphate receptors, affecting GPR12 indirectly by influencing the sphingosine-related pathways, which are integral to GPR12's role in cellular signaling. Cannabidiol (CBD) and CP-55,940 modulate the endocannabinoid system, which shares signaling pathways with GPR12, and their interactions can lead to an enhanced functional activity of GPR12. Lastly, capsaicin, by binding to the vanilloid receptor, influences GPR12 activity through downstream effectors such as calcium ions and protein kinase C (PKC), highlighting the diverse yet specific ways in which these compounds can enhance the functionality of GPR12.
제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
디부티릴 cAMP는 세포 내 cAMP 수준을 증가시켜 단백질 키나아제 A(PKA) 및 기타 다운스트림 신호 이벤트를 포함한 cAMP 의존 경로의 활성화를 유도하는 사이클릭 AMP(cAMP)의 유사체입니다. 이러한 경로는 GPCR 신호에 간접적으로 영향을 미칠 수 있습니다. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA는 다양한 세포 내 신호 경로를 조절할 수 있는 단백질 키나아제 C(PKC)의 강력한 활성화제입니다. PKC 활성화는 GPCR 신호에 간접적으로 영향을 미칠 수 있습니다. | ||||||
Calphostin C | 121263-19-2 | sc-3545 sc-3545A | 100 µg 1 mg | $336.00 $1642.00 | 20 | |
칼포스틴 C는 PKC의 억제제로, GPCR 신호와 교차하는 다운스트림 신호 경로에 잠재적으로 영향을 미칠 수 있습니다. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
롤리프람은 포스포디에스테라아제 4(PDE4)의 선택적 억제제로, cAMP 수치를 높이고 cAMP 의존 경로를 활성화하여 GPCR 신호에 간접적으로 영향을 미칩니다. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $102.00 $347.00 | 7 | |
8-Br-cGMP는 cGMP에 의해 조절되는 세포 프로세스에 영향을 미칠 수 있는 순환 GMP(cGMP)의 유사체로, 잠재적으로 GPCR 매개 경로와 교차할 수 있습니다. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
워트만닌은 PI3K/Akt 신호 전달 경로의 핵심 역할을 하는 포스포이노시타이드 3-키나아제(PI3K)의 억제제로, GPCR 신호 전달 경로와 교차할 수 있습니다. |